Crescita Therapeutics Inc. (CTX.TO)
CAD 0.59
(0.0%)
CAD 0.59
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.25 Million CAD | -22.26% |
| 2022 | 1.61 Million CAD | -43.76% |
| 2021 | 2.86 Million CAD | 133.17% |
| 2020 | 1.23 Million CAD | -20.54% |
| 2019 | 1.54 Million CAD | -64.89% |
| 2018 | 4.4 Million CAD | 2.2% |
| 2017 | 4.31 Million CAD | -47.16% |
| 2016 | 8.16 Million CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.03 Million CAD | -9.6% |
| 2024 Q1 | 1.14 Million CAD | -8.61% |
| 2023 FY | 1.25 Million CAD | -22.26% |
| 2023 Q1 | 1.51 Million CAD | -6.14% |
| 2023 Q2 | 1.41 Million CAD | -6.67% |
| 2023 Q3 | 1.31 Million CAD | -7.29% |
| 2023 Q4 | 1.25 Million CAD | -4.27% |
| 2022 Q3 | 1.61 Million CAD | -5.38% |
| 2022 Q1 | 2.78 Million CAD | -2.75% |
| 2022 FY | 1.61 Million CAD | -43.76% |
| 2022 Q2 | 1.71 Million CAD | -38.69% |
| 2022 Q4 | 1.61 Million CAD | -0.31% |
| 2021 Q1 | 3.08 Million CAD | 151.06% |
| 2021 Q4 | 2.86 Million CAD | -2.65% |
| 2021 Q3 | 2.94 Million CAD | -2.35% |
| 2021 Q2 | 3.01 Million CAD | -2.3% |
| 2021 FY | 2.86 Million CAD | 133.17% |
| 2020 Q2 | 1.39 Million CAD | -5.37% |
| 2020 Q1 | 1.47 Million CAD | -4.91% |
| 2020 Q4 | 1.23 Million CAD | -6.25% |
| 2020 Q3 | 1.31 Million CAD | -5.81% |
| 2020 FY | 1.23 Million CAD | -20.54% |
| 2019 Q4 | 1.54 Million CAD | -70.08% |
| 2019 Q2 | 5.24 Million CAD | -1.21% |
| 2019 FY | 1.54 Million CAD | -64.89% |
| 2019 Q1 | 5.3 Million CAD | 20.3% |
| 2019 Q3 | 5.17 Million CAD | -1.26% |
| 2018 Q1 | 4.33 Million CAD | 0.53% |
| 2018 FY | 4.4 Million CAD | 2.2% |
| 2018 Q4 | 4.4 Million CAD | 0.57% |
| 2018 Q3 | 4.38 Million CAD | 0.55% |
| 2018 Q2 | 4.36 Million CAD | 0.53% |
| 2017 Q3 | 4.29 Million CAD | -45.2% |
| 2017 Q2 | 7.83 Million CAD | -2.82% |
| 2017 FY | 4.31 Million CAD | -47.16% |
| 2017 Q1 | 8.05 Million CAD | -1.29% |
| 2017 Q4 | 4.31 Million CAD | 0.51% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | 8.16 Million CAD | -1.26% |
| 2016 Q3 | 8.26 Million CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 FY | 8.16 Million CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 104.79 Million CAD | 98.803% |
| Avicanna Inc. | 1.8 Million CAD | 30.465% |
| Avant Brands Inc. | 18.7 Million CAD | 93.295% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -691.007% |
| Knight Therapeutics Inc. | 69.09 Million CAD | 98.185% |
| MediPharm Labs Corp. | 2.29 Million CAD | 45.359% |
| OrganiGram Holdings Inc. | 155 Thousand CAD | -709.032% |
| Canopy Growth Corporation | 683.17 Million CAD | 99.816% |
| Willow Biosciences Inc. | 2.15 Million CAD | 41.837% |
| Auxly Cannabis Group Inc. | 159.04 Million CAD | 99.212% |